Conditions
Surgical Applications

Surgical Applications

Surgical Management of Cardiogenic Shock

Surgical applications for Impella® heart pumps include:

  • Ongoing cardiogenic shock that occurs immediately (< 48 hours) following acute myocardial infarction or open-heart surgery
  • Cardiogenic shock in the setting of cardiomyopathy, including peripartum cardiomyopathy, or myocarditis as a result of isolated left ventricular failure that is not responsive to optimal medical management and conventional treatment measures 
  • Emergency use authorization for temporary LV unloading and support to treat critical care patients with confirmed COVID-19 infection who are undergoing ECMO treatment and who develop pulmonary edema while on ECMO support or late cardiac decompensation from myocarditis while on ECMO support

Resources for Surgical Best Practices

Patient Identification

Which patients should be considered for escalation with a surgically-implanted Impella® heart pump?

Learn More

Clinical Evidence

Review clinical data supporting the benefits of Impella and clinical trials that are upcoming or ongoing.

Learn More

The Procedure

Learn more about surgical techniques for implanting Impella heart pumps.

Learn More

Patient Management

Explore patient management topics relevant to surgical applications.

Learn More

NPS-1308

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].

The Protected PCI community
is now on HeartRecovery.com

Providing education and training to help health care professionals
recover hearts, oxygenate the body and save lives.
Explore Now